🇺🇸 Dexmedetomidine prolonged sedation in United States

Dexmedetomidine prolonged sedation (Dexmedetomidine prolonged sedation) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Dexmedetomidine prolonged sedation in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Dexmedetomidine prolonged sedation approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Dexmedetomidine prolonged sedation in United States?

Beijing Chao Yang Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.